NovoCure Ltd — Director's Dealing 2018

Jun 19, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-06-18

Reporting Person: Danziger Asaf (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-18	Ordinary Shares	S	22289	$32.00	Disposed	148611	Direct

Footnotes

F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger.